This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Colorado. Active years: 2011-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2019
Title: Innovations by Catherine Haluszczak
Introduction
Catherine Haluszczak is a prominent inventor based in Centennial, CO (US). She has made significant contributions to the field of immunology, particularly in the development of novel therapeutic approaches. With a total of 5 patents to her name, her work focuses on enhancing vaccine efficacy and treating chronic diseases.
Latest Patents
One of her latest patents is titled "Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferon." This patent describes a synergistic adjuvant that comprises effective amounts of at least one type 1 interferon and at least one CD40 agonist. These components can be formulated in the same or separate compositions. Additionally, the patent includes fusion proteins and DNA conjugates that combine type 1 interferon, CD40 agonist, and antigen. The applications of these compositions as immune adjuvants are aimed at treating chronic diseases such as HIV infection and enhancing the efficacy of both prophylactic and therapeutic vaccines.
Another significant patent is "Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody." Similar to her previous work, this patent outlines a synergistic adjuvant that includes type 1 interferon and CD40 agonist. The use of these innovative compositions, protein, and DNA conjugates as immune adjuvants is also emphasized for their potential in treating chronic diseases and improving vaccine effectiveness.
Career Highlights
Catherine Haluszczak is affiliated with the University of Colorado, where she conducts her research and development work. Her innovative approaches have positioned her as a key figure in the field of immunology.
Collaborations
Catherine has collaborated with notable colleagues, including Ross M Kedl and Phillip J Sanchez. Their combined expertise contributes to the advancement of research in immunological therapies.
Conclusion
Catherine Haluszczak's contributions to immunology through her patents and research at the University of Colorado highlight her role as an influential inventor. Her work continues to pave the way for advancements in vaccine efficacy and chronic disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile